Risk Perception in a Real-World Situation (COVID-19): How It Changes From 18 to 87 Years Old

被引:83
|
作者
Rosi, Alessia [1 ]
van Vugt, Floris Tijmen [1 ,2 ]
Lecce, Serena [1 ]
Ceccato, Irene [3 ]
Vallarino, Martine [1 ]
Rapisarda, Filippo [4 ]
Vecchi, Tomaso [1 ,5 ]
Cavallini, Elena [1 ]
机构
[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[2] Univ Montreal, Dept Psychol, Montreal, PQ, Canada
[3] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy
[4] Sociosfera ONLUS SCS, Seregno, Italy
[5] IRCCS, Mondino Fdn, Cognit Psychol Unit, Pavia, Italy
来源
FRONTIERS IN PSYCHOLOGY | 2021年 / 12卷
关键词
risk perception; COVID-19; anxiety; emotion; availability heuristic; JUDGMENT; MODEL;
D O I
10.3389/fpsyg.2021.646558
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Studies on age-related differences in risk perception in a real-world situation, such as the recent COVID-19 outbreak, showed that the risk perception of getting COVID-19 tends to decrease as age increases. This finding raised the question on what factors could explain risk perception in older adults. The present study examined age-related differences in risk perception in the early stages of COVID-19 lockdown, analyzing variables that can explain the differences in perception of risk at different ages. A total of 1,765 adults aged between 18 and 87 years old completed an online survey assessing perceived risk severity and risk vulnerability of getting COVID-19, sociodemographic status, emotional state, experience relating to COVID-19, and physical health status. Results showed that the older the participants, the lower the perceived vulnerability to getting COVID-19, but the higher the perceived severity. Different predictors explain the perception of risk severity and vulnerability at different ages. Overall, self-reported anxiety over the pandemic is a crucial predictor in explaining risk perceptions in all age groups. Theoretical and practical implications of the empirical findings are discussed.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Gastrointestinal Manifestations and Liver Abnormalities in COVID-19: A Real-World Experience and a Novel COVID-19 Prognostic Index
    Manrai, Manish
    Marwah, Vikas
    Peter, Deepu
    Mangal, Vishal
    Harikrishnan, P.
    Mishra, Yogendra
    Sharma, Manish
    Pemmaraju, Arpitha
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2023, 17 (07) : OC10 - OC16
  • [42] Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan
    Shida, Haruka
    Komamine, Maki
    Kajiyama, Kazuhiro
    Waki, Takashi
    Maruyama, Hotaka
    Uyama, Yoshiaki
    PLOS ONE, 2024, 19 (01):
  • [43] Sex differences in comorbidities and COVID-19 mortality-Report from the real-world data
    Yoshida, Yilin
    Wang, Jia
    Zu, Yuanhao
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [44] Antithrombotic Use Patterns in COVID-19 Patients from Spain: A Real-World Data Study
    Ramirez-Cervantes, Karen Lizzette
    Campillo-Morales, Salvador
    Garcia-Poza, Patricia
    Quintana-Diaz, Manuel
    Huerta-Alvarez, Consuelo
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [45] COVID-19 in Adults with Sickle Cell Disease: Data from Cerner Real-World Database
    Guarino, Stephanie H.
    Gbadebo, Bayo
    Caplan, Richard
    Ndura, Kevin
    Jurkovitz, Claudine
    BLOOD, 2022, 140 : 13172 - 13173
  • [46] Pulmonary Therapy Podcast—COVID-19: Research and Real-World Experiences from the Editorial Board
    Kai Michael Beeh
    Nazia Chaudhuri
    Timothy J. Craig
    Alan Kaplan
    Marcus Peter Kennedy
    Pulmonary Therapy, 2021, 7 : 1 - 7
  • [47] Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital
    Nadia Ninosu
    Fabio Roehrich
    Katharina Diehl
    Wiebke K. Peitsch
    Marthe-Lisa Schaarschmidt
    European Journal of Dermatology, 2021, 31 : 183 - 191
  • [48] REAL-WORLD EFFECTIVENESS OF EARLY TREATMENTS FOR COVID-19: EVIDENCE FROM ADMINISTRATIVE CLAIMS DATA
    Bell, C.
    Lokhandwala, T.
    Gibbons, D.
    Patel, V
    Drysdale, M.
    Wang, J.
    Lloyd, E.
    VALUE IN HEALTH, 2023, 26 (06) : S24 - S24
  • [49] Psoriasis care during the time of COVID-19: real-world data on changes in treatments and appointments from a German university hospital
    Ninosu, Nadia
    Roehrich, Fabio
    Diehl, Katharina
    Peitsch, Wiebke K.
    Schaarschmidt, Marthe-Lisa
    EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31 (02) : 183 - 191
  • [50] Use of Real-World Electronic Health Records to Estimate Risk, Risk Factors, and Disparities for COVID-19 in Patients With Cancer
    Desai, Aakash
    Khaki, Ali Raza
    Kuderer, Nicole M.
    JAMA ONCOLOGY, 2021, 7 (02) : 227 - 229